New Era of Precision
Personalized Precision Care
AMPEL is committed to commercializing products to improve clinical care for patients and leveraging its AMPEL Genomic Platform (AGP®) into other disease areas.
Support Management of Autoimmune and Inflammatory Diseases
Provides insights into state of disease
Predicts drug options (right drug for the right patient at the right time)
Improves clinical outcomes and reduces healthcare costs
Patient-Centric 1st Product for Lupus
Medically validated mobile app that collects ePRO data informs the patient/doctor of their disease status & suggests the need for a medication change, leading to a LuGENE® blood test.
LuGENE® Blood Test
Evaluates a patient’s genomics to understand where they are in their disease progression. With this information, it can identify a needed medication change.